Wern David Timothy 4
4 · SANUWAVE Health, Inc. · Filed Feb 3, 2026
Research Summary
AI-generated summary of this filing
SANUWAVE (SNVW) Exec VP Wern David Timothy Receives 2,500-Share Award
What Happened
Wern David Timothy, Executive Vice President of Sales at SANUWAVE Health, Inc. (SNVW), received a grant of 2,500 derivative securities (reported as an award) on January 30, 2026. The filing shows a reported price of $0.00 for the award (total reported cash consideration $0). This is a compensation award rather than an open-market purchase or sale.
Key Details
- Transaction date: 2026-01-30 (Form 4 filed 2026-02-03; filing appears timely — within the two business-day window required for Form 4s).
- Transaction type/code: A — Grant/award of a derivative security.
- Quantity: 2,500 derivative shares/options; reported price $0.00 (no cash paid reported).
- Vesting: Options will vest over three years in 12 equal installments on each quarterly anniversary of the grant date (footnote).
- Shares owned after transaction: Not specified in the information provided in this summary (not disclosed in the excerpt).
- Notable: This is a compensation award (routine for employees/executives); not a market buy or sale.
Context This award is a typical compensation/retention grant and should be viewed differently from open-market purchases (which can signal personal conviction) or sales. The footnote indicates these are options that vest quarterly over three years; the filing does not disclose an exercise price or immediate cash value in the provided excerpt.
Insider Transaction Report
- Award
Stock Option (right to buy)
[F1]2026-01-30+2,500→ 2,500 totalExercise: $26.96Exp: 2036-01-30→ Common Stock (2,500 underlying)
Footnotes (1)
- [F1]Options will vest over a period of three years in 12 equal installments on each quarterly anniversary of the grant date.